Mesabi Trust (MSB) Financials

MSB

FY2025 annual

Revenue $98.6M +331.3% YoY

Net Income $93.3M +391.3% YoY

Operating Cash Flow $93.9M +543.1% YoY

Gross Profit $93.3M +391.3% YoY

Market Cap $248.0M as of Oct 3, 2026

Price / Sales 2.5x on $98.6M revenue, FY2025

Price / Earnings 2.7x on $93.3M net income, FY2025

Price / Book 14.1x on $17.6M equity, Q2 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2027, ended Jul 31, 2026 Reported Sep 11, 2026 Currency USD FYE January

Newest figures come from the 10-Q for Q2 FY2027, filed Sep 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MSB SEC filings page.

Mesabi Trust (MSB) reported $98.6M in revenue for fiscal year 2025, up 331.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MSB FY2025 2026-08-30

High margins and cash distribution define Mesabi Trust, while FY2025 brought a much more liability-heavy financing structure.

Cash conversion is unusually tight: FY2025 reported net income of $93.3M and operating cash flow of $93.9M were nearly identical, indicating that reported earnings were largely realized as cash. The margin rebound from 83.0% in FY2024 to 94.6% in FY2025 occurred alongside the revenue rebound, suggesting sensitivity to revenue composition or underlying activity levels rather than a stable margin base.

Revenue volatility is the operating signature: it moved from $7.7M in FY2023 to $98.6M in FY2025, meaning a single year's payout capacity may not represent a normal period. Dividends paid were $4.6M in FY2025, a much smaller distribution relative to that year's operating cash flow than the figures reported in earlier years.

Balance-sheet leverage changed abruptly: reported debt-to-equity reached 3.4x in FY2025 from 0.3x a year earlier, a materially different financing posture. Total liabilities of $78.4M against $23.3M of equity reinforce that the latest asset base is more liability-funded than in FY2024.

Financial Health Signals

Financial health score not available

Mesabi Trust does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

7/7

Mesabi Trust passes 7 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 1 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.01x

For every $1 of reported earnings, Mesabi Trust generates $1.01 in operating cash flow ($93.9M OCF vs $93.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.5M

YoY-55.8%

QoQ+10.4%

Mesabi Trust generated $2.5M in revenue in Q2 2027. This represents a decrease of 55.8% from the same quarter a year earlier. Against the prior quarter it is up 10.4%.

Net Income

-$95K

YoY-102.0%

QoQ-108.7%

Mesabi Trust reported -$95K in net income in Q2 2027. This represents a decrease of 102.0% from the same quarter a year earlier. Against the prior quarter it is down 108.7%.

EBITDA

Not reported for Q2 2027.

EPS (Diluted)

Not reported for Q2 2027.

Cash & Balance Sheet

Cash & Debt

$17.4M

YoY-18.2%

QoQ-14.3%

5Y CAGR-9.3%

10Y CAGR+10.7%

Mesabi Trust held $17.4M in cash as of Q2 2027; long-term debt is not reported for that period.

Shares Outstanding

13M

YoY0.0%

QoQ0.0%

Mesabi Trust had 13M shares outstanding in Q2 2027. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q2 2027.

Dividends Per Share

Not reported for Q2 2027.

Margins & Returns

Gross Margin

-3.8%

YoY-88.4pp

QoQ-52.3pp

Mesabi Trust's gross margin was -3.8% in Q2 2027, indicating the percentage of revenue retained after direct costs. This is down 88.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 52.3 percentage points.

Net Margin

-3.8%

YoY-88.4pp

QoQ-52.3pp

Mesabi Trust's net profit margin was -3.8% in Q2 2027, showing the share of revenue converted to profit. This is down 88.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 52.3 percentage points.

Return on Equity

-0.5%

YoY-21.4pp

QoQ-6.5pp

Mesabi Trust's ROE was -0.5% in Q2 2027, measuring profit generated per dollar of shareholder equity. This is down 21.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.5 percentage points.

Operating Margin

Not reported for Q2 2027.

Capital Allocation

None of these metrics is reported for Q2 2027.

MSB Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MSB quarterly income statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$98.6M+331.3%	$22.9M+195.3%	$7.7M-89.2%	$71.5M+175.4%	$26.0M-18.9%	$32.0M-32.4%	$47.3M+37.1%	$34.5M+216.8%	$10.9M+12.0%	$9.7M-62.7%	$26.1M+18.3%	$22.0M-30.2%	$31.6M-7.6%	$34.2M+2.4%	$33.3M
Cost of Revenue	$5.3M+37.2%	$3.9M+59.4%	$2.4M-9.7%	$2.7M+5.9%	$2.5M+31.4%	$1.9M+11.6%	$1.7M+61.8%	$1.1M-4.6%	$1.1M	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$93.3M+391.3%	$19.0M+257.6%	$5.3M-92.3%	$68.8M+193.8%	$23.4M-22.1%	$30.1M-34.0%	$45.6M+36.3%	$33.4M+242.3%	$9.8M	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.1M-4.6%	$1.1M-3.4%	$1.2M-11.4%	$1.3M	N/A	N/A	$921K+4.8%	$879K
Interest Expense	$2.0M+154.1%	$769K+213.2%	$246K-53.1%	$523K+1374.7%	$35K-87.5%	$283K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$93.3M+391.3%	$19.0M+257.6%	$5.3M-92.3%	$68.8M+193.8%	$23.4M-22.1%	$30.1M-34.0%	$45.6M+36.3%	$33.4M+242.3%	$9.8M+14.1%	$8.6M-65.4%	$24.8M+17.6%	$21.1M-31.3%	$30.7M-7.8%	$33.2M+2.4%	$32.5M
EPS (Basic)	$7.11+391.3%	$1.45+257.3%	$0.41-92.3%	$5.24+193.8%	$1.78-22.1%	$2.29-34.0%	$3.47+36.3%	$2.55+242.5%	$0.74+14.1%	$0.65-65.5%	$1.89+17.6%	$1.60-31.3%	$2.34-7.8%	$2.53+2.4%	$2.47
Diluted Shares (Avg)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	13M0.0%	13M0.0%	13M0.0%	13M	N/A

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q
Revenue	$2.5M-55.8%	$2.2M-52.6%	N/A	$3.6M-95.5%	$5.6M-13.6%	$4.7M-24.3%	$6.9M+10.0%	$79.0M+1513.6%
Cost of Revenue	$2.6M+198.5%	$1.2M+5.0%	N/A	$823K+21.7%	$863K-21.0%	$1.1M-60.1%	$786K-48.8%	$676K-16.5%
Gross Profit	-$95K-102.0%	$1.1M-70.1%	N/A	$2.8M-96.5%	$4.7M-12.1%	$3.6M+4.2%	$6.1M+29.3%	$78.3M+1816.9%
Interest Expense	N/A	$168K-56.4%	N/A	$200K-57.3%	$190K-19.3%	$385K+60.5%	$1.0M+319.3%	$468K+101.9%
Net Income	-$95K-102.0%	$1.1M-70.1%	N/A	$2.8M-96.5%	$4.7M-12.1%	$3.6M+4.2%	$6.1M+29.3%	$78.3M+1816.9%
EPS (Basic)	-$0.01-102.0%	$0.08-70.1%	N/A	$0.21-96.5%	$0.36-12.1%	$0.28+4.3%	$0.46+29.2%	$5.97+1817.1%

Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Income Tax, EPS (Diluted), Diluted Shares (Avg).

MSB Balance Sheet

MSB quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$101.7M+281.1%	$26.7M+89.1%	$14.1M-73.8%	$53.9M+135.1%	$22.9M-3.0%	$23.6M-33.3%	$35.5M+35.2%	$26.2M+84.0%	$14.2M+45.2%	$9.8M-2.8%	$10.1M+18.0%	$8.6M+11.9%	$7.6M-31.5%	$11.2M+15.8%	$9.6M
Current Assets	$101.7M+281.1%	$26.7M+89.1%	$14.1M-73.8%	$53.9M+135.1%	$22.9M-3.0%	$23.6M-33.3%	$35.5M+35.2%	$26.2M+84.0%	$14.2M+52.2%	$9.4M-4.9%	$9.8M+22.4%	$8.0M+8.1%	$7.4M-30.4%	$10.7M+10.9%	$9.6M
Cash & Equivalents	$100.2M+317.9%	$24.0M+71.7%	$14.0M-70.7%	$47.7M+281.8%	$12.5M+22.8%	$10.2M+1054.2%	$882K+180.1%	$315K-97.7%	$13.7M+429.4%	$2.6M-70.3%	$8.7M+12.9%	$7.7M+14.8%	$6.7M-34.4%	$10.3M+17.9%	$8.7M
Short-Term Investments	$0	$0	$0	$0-100.0%	$9.9M-25.7%	$13.3M-58.5%	$32.1M+35.0%	$23.8M+5118.1%	$456K-92.1%	$5.7M	$0	$0	$0	$0	$0
Accounts Receivable	$1.2M-40.8%	$2.0M+8220.0%	$24K-99.5%	$4.6M+1756.5%	$249K+258.5%	$70K-97.0%	$2.3M+19.6%	$2.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$456K	$0	$0	$0	$0	$0
Total Liabilities	$78.4M+1271.8%	$5.7M+113.3%	$2.7M-88.4%	$23.1M+258.3%	$6.5M-45.4%	$11.8M-36.6%	$18.6M+19.4%	$15.6M+286.1%	$4.0M+388.6%	$828K-90.2%	$8.5M+12.1%	$7.6M+17.1%	$6.5M-36.2%	$10.1M+17.1%	$8.7M
Total Equity	$23.3M+11.2%	$21.0M+83.4%	$11.4M-62.9%	$30.8M+86.9%	$16.5M+39.3%	$11.8M-29.6%	$16.8M+58.4%	$10.6M+3.9%	$10.2M+13.5%	$9.0M+457.9%	$1.6M+63.7%	$984K-16.8%	$1.2M+14.6%	$1.0M+4.4%	$988K

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q
Total Assets	$19.8M-19.9%	$21.9M-20.1%	$24.4M-76.1%	$26.0M-74.2%	$24.8M-5.6%	$27.4M+9.1%	$101.7M+281.1%	$100.7M+287.0%
Current Assets	$19.8M-19.9%	$21.9M-20.1%	$24.4M-76.1%	$26.0M-74.2%	$24.8M-5.6%	$27.4M+9.1%	$101.7M+281.1%	$100.7M+287.0%
Cash & Equivalents	$17.4M-18.2%	$20.3M-16.3%	$23.2M-76.9%	$23.2M-75.8%	$21.2M-1.8%	$24.2M+12.0%	$100.2M+317.9%	$95.9M+318.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$968K-33.0%	$632K-67.0%	$782K-32.6%	$1.5M-60.8%	$1.4M-44.1%	$1.9M+4.8%	$1.2M-40.8%	$3.9M+106.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$2.3M+12.9%	$3.6M-54.2%	$4.0M-95.0%	$4.9M-8.1%	$2.0M-51.7%	$7.8M+74.6%	$78.4M+1271.8%	$5.3M+9.6%
Total Equity	$17.6M-22.8%	$18.3M-6.5%	$20.4M-12.5%	$21.1M-77.9%	$22.8M+3.0%	$19.6M-5.0%	$23.3M+11.2%	$95.3M+350.9%

Not reported in any period shown, so not listed: Inventory, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt, Retained Earnings.

MSB Cash Flow Statement

MSB quarterly cash flow statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$93.9M+543.1%	$14.6M+5.3%	$13.9M-77.9%	$62.8M+202.0%	$20.8M-39.8%	$34.6M-24.0%	$45.5M+54.2%	$29.5M+134.5%	$12.6M+53.1%	$8.2M-66.1%	$24.3M+14.1%	$21.3M-30.7%	$30.7M-7.3%	$33.1M+9.1%	$30.4M
Investing Cash Flow	N/A	N/A	N/A	$9.9M+189.2%	$3.4M-81.8%	$18.8M+325.7%	-$8.3M+64.3%	-$23.3M-506.6%	$5.7M+205.7%	-$5.4M	N/A	N/A	N/A	N/A	N/A
Dividends Paid	$4.6M0.0%	$4.6M-90.4%	$47.6M+26.9%	$37.5M+71.3%	$21.9M-50.3%	$44.1M+20.4%	$36.6M+87.2%	$19.5M+170.9%	$7.2M-19.1%	$8.9M-61.6%	$23.2M	N/A	N/A	N/A	N/A

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q
Operating Cash Flow	$249K-94.3%	$534K-74.4%	N/A	$3.5M-95.5%	$4.4M+15.0%	$2.1M-16.9%	$9.4M+66.3%	$78.2M+1415.3%
Dividends Paid	$3.1M-57.1%	$3.4M-95.6%	N/A	$1.6M-60.0%	$7.3M+93.1%	$78.1M+1508.1%	-$8.0M	$3.9M

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Share Buybacks.

MSB Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MSB quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	94.6%+11.6pp	83.0%+14.5pp	68.6%-27.7pp	96.2%+6.0pp	90.2%-3.7pp	94.0%-2.4pp	96.3%-0.6pp	96.9%+7.2pp	89.7%	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	94.6%+11.6pp	83.0%+14.5pp	68.6%-27.7pp	96.2%+6.0pp	90.2%-3.7pp	94.0%-2.4pp	96.3%-0.6pp	96.9%+7.2pp	89.7%+1.6pp	88.0%-6.9pp	95.0%-0.5pp	95.5%-1.6pp	97.1%-0.2pp	97.3%-0.1pp	97.4%
Return on Equity	399.8%+309.3pp	90.5%+44.1pp	46.4%-176.9pp	223.3%+81.2pp	142.1%-112.0pp	254.0%-17.1pp	271.1%-44.0pp	315.1%+219.4pp	95.7%+0.5pp	95.2%-1442.1pp	1537.3%-602.4pp	2139.7%-453.3pp	2593.0%-629.2pp	3222.2%-64.2pp	3286.4%
Return on Assets	91.7%+20.6pp	71.1%+33.5pp	37.6%-89.9pp	127.6%+25.5pp	102.1%-25.0pp	127.1%-1.4pp	128.5%+1.0pp	127.5%+58.9pp	68.5%-18.7pp	87.2%-158.1pp	245.3%-0.9pp	246.2%-154.8pp	400.9%+103.3pp	297.6%-39.0pp	336.6%
Debt-to-Equity	3.36+3.1x	0.270.0x	0.23-0.5x	0.75+0.4x	0.39-0.6x	1.00-0.1x	1.11-0.4x	1.47+1.1x	0.40+0.3x	0.09-5.2x	5.27-2.4x	7.69+2.2x	5.47-4.4x	9.83+1.1x	8.76
Asset Turnover	0.97+0.1x	0.86+0.3x	0.55-0.8x	1.33+0.2x	1.13-0.2x	1.350.0x	1.330.0x	1.32+0.6x	0.76-0.2x	0.99-1.6x	2.580.0x	2.58-1.6x	4.13+1.1x	3.06-0.4x	3.46

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q
Gross Margin	-3.8%-88.4pp	48.4%-28.3pp	N/A	77.1%-22.1pp	84.6%+1.4pp	76.7%+21.0pp	88.5%+13.2pp	99.1%+15.7pp
Net Margin	-3.8%-88.4pp	48.4%-28.3pp	N/A	77.1%-22.1pp	84.6%+1.4pp	76.7%+21.0pp	88.5%+13.2pp	99.1%+15.7pp
Return on Equity	-0.5%-21.4pp	5.9%-12.6pp	N/A	13.1%-69.0pp	20.8%-3.6pp	18.5%+1.7pp	26.0%+3.7pp	82.2%+62.8pp
Return on Assets	-0.5%-19.6pp	5.0%-8.3pp	N/A	10.6%-67.2pp	19.1%-1.4pp	13.2%-0.6pp	6.0%-11.6pp	77.8%+62.1pp
Debt-to-Equity	0.130.0x	0.20-0.2x	0.19-3.2x	0.23+0.2x	0.09-0.1x	0.40+0.2x	3.36+3.1x	0.06-0.2x
Asset Turnover	0.13-0.1x	0.10-0.1x	N/A	0.14-0.6x	0.230.0x	0.17-0.1x	0.07-0.2x	0.78+0.6x

Not reported in any period shown, so not listed: Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Mesabi Trust MSB	FY2025	$98.6M	$93.3M	94.6%	$248.0M	—
Luda Technology Group Limited LUD	FY2025	$33.5M	$557K	1.7%	$86.7M	38/100
Algoma Steel Group Inc. ASTL	FY2025	N/A	-$984.9M	N/A	$458.6M	—
Olympic Steel, Inc. ZEUS	FY2024	$1.9B	$23.0M	1.2%	$539.0M	44/100
NWPX Infrastructure, Inc. NWPX	FY2025	$526.0M	$35.4M	6.7%	$1.0B	71/100
Metallus Inc. MTUS	FY2025	$1.2B	-$1.2M	-0.1%	$824.4M	20/100

Where Mesabi Trust Ranks

Frequently Asked Questions

What is Mesabi Trust's annual revenue?

Mesabi Trust (MSB) reported $98.6M in total revenue for fiscal year 2025. This represents a 331.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Mesabi Trust's revenue growing?

Mesabi Trust (MSB) revenue grew by 331.3% year-over-year, from $22.9M to $98.6M in fiscal year 2025.

Is Mesabi Trust profitable?

Yes, Mesabi Trust (MSB) reported a net income of $93.3M in fiscal year 2025, with a net profit margin of 94.6%.

What is Mesabi Trust's gross margin?

Mesabi Trust (MSB) had a gross margin of 94.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Mesabi Trust's net profit margin?

Mesabi Trust (MSB) had a net profit margin of 94.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Mesabi Trust's return on equity (ROE)?

Mesabi Trust (MSB) has a return on equity of 399.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Mesabi Trust's operating cash flow?

Mesabi Trust (MSB) generated $93.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Mesabi Trust's total assets?

Mesabi Trust (MSB) had $101.7M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Mesabi Trust have outstanding?

Mesabi Trust (MSB) had 13M shares outstanding as of fiscal year 2025.

What is Mesabi Trust's debt-to-equity ratio?

Mesabi Trust (MSB) had a debt-to-equity ratio of 3.36 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Mesabi Trust's return on assets (ROA)?

Mesabi Trust (MSB) had a return on assets of 91.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Mesabi Trust's P/E ratio?

Mesabi Trust (MSB) trades at 2.7x earnings, its market capitalization divided by net income of $93.3M net income, FY2025. The market capitalization is $248.0M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Mesabi Trust's price-to-sales ratio?

Mesabi Trust (MSB) trades at 2.5x sales, its market capitalization divided by revenue of $98.6M revenue, FY2025. The market capitalization is $248.0M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Mesabi Trust's Piotroski F-Score?

Mesabi Trust (MSB) has a Piotroski F-Score of 7 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Mesabi Trust's earnings high quality?

Mesabi Trust (MSB) has an earnings quality ratio of 1.01x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.